| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 31 | 2023 | 132 | 5.790 |
Why?
|
| Nicotine | 13 | 2023 | 202 | 1.930 |
Why?
|
| Nicotinic Agonists | 6 | 2017 | 74 | 1.450 |
Why?
|
| Protein Processing, Post-Translational | 16 | 2017 | 405 | 1.370 |
Why?
|
| Receptors, AMPA | 7 | 2017 | 66 | 1.340 |
Why?
|
| Tobacco Use Disorder | 4 | 2023 | 116 | 1.310 |
Why?
|
| Lipoylation | 7 | 2016 | 37 | 1.220 |
Why?
|
| Endoplasmic Reticulum | 10 | 2021 | 258 | 1.210 |
Why?
|
| Dendrites | 4 | 2021 | 103 | 1.150 |
Why?
|
| Membrane Proteins | 12 | 2021 | 1237 | 1.090 |
Why?
|
| Golgi Apparatus | 3 | 2021 | 117 | 1.030 |
Why?
|
| Up-Regulation | 10 | 2024 | 727 | 0.940 |
Why?
|
| Neurons | 16 | 2021 | 1597 | 0.920 |
Why?
|
| Molecular Chaperones | 3 | 2017 | 123 | 0.920 |
Why?
|
| Protein Subunits | 5 | 2009 | 123 | 0.860 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2017 | 190 | 0.860 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2016 | 316 | 0.850 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2016 | 89 | 0.850 |
Why?
|
| Animals | 67 | 2024 | 27828 | 0.840 |
Why?
|
| Membrane Glycoproteins | 4 | 2021 | 434 | 0.840 |
Why?
|
| Rats | 20 | 2021 | 4057 | 0.830 |
Why?
|
| HEK293 Cells | 9 | 2021 | 660 | 0.830 |
Why?
|
| Bungarotoxins | 14 | 2010 | 25 | 0.830 |
Why?
|
| Receptors, Cholinergic | 11 | 2008 | 77 | 0.780 |
Why?
|
| Varenicline | 2 | 2022 | 15 | 0.770 |
Why?
|
| Guanylate Kinases | 2 | 2013 | 12 | 0.760 |
Why?
|
| Cell Line | 23 | 2010 | 2506 | 0.750 |
Why?
|
| Murine Acquired Immunodeficiency Syndrome | 3 | 2013 | 3 | 0.750 |
Why?
|
| Synapses | 7 | 2017 | 281 | 0.730 |
Why?
|
| Palmitic Acid | 5 | 2006 | 29 | 0.700 |
Why?
|
| Post-Synaptic Density | 2 | 2017 | 7 | 0.700 |
Why?
|
| Protein Transport | 13 | 2020 | 429 | 0.680 |
Why?
|
| Superoxide Dismutase-1 | 2 | 2017 | 48 | 0.650 |
Why?
|
| Protein Multimerization | 2 | 2017 | 182 | 0.620 |
Why?
|
| Ion Channels | 8 | 2014 | 246 | 0.610 |
Why?
|
| Brain | 9 | 2023 | 2334 | 0.590 |
Why?
|
| Spinal Cord | 2 | 2017 | 256 | 0.590 |
Why?
|
| Proteins | 5 | 2020 | 800 | 0.570 |
Why?
|
| Hippocampus | 6 | 2017 | 442 | 0.550 |
Why?
|
| Disks Large Homolog 4 Protein | 1 | 2016 | 7 | 0.550 |
Why?
|
| Receptors, Glutamate | 1 | 2016 | 24 | 0.550 |
Why?
|
| Ligands | 7 | 2023 | 453 | 0.540 |
Why?
|
| Calnexin | 2 | 2007 | 4 | 0.540 |
Why?
|
| Mice | 29 | 2024 | 12013 | 0.530 |
Why?
|
| Nerve Tissue Proteins | 5 | 2011 | 511 | 0.520 |
Why?
|
| Protein Conformation | 10 | 2013 | 903 | 0.480 |
Why?
|
| Endosomes | 1 | 2015 | 82 | 0.470 |
Why?
|
| Transfection | 11 | 2015 | 910 | 0.460 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2010 | 320 | 0.450 |
Why?
|
| Smoking Cessation | 1 | 2017 | 265 | 0.450 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2013 | 3 | 0.450 |
Why?
|
| Gammaretrovirus | 1 | 2013 | 4 | 0.450 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 16 | 0.450 |
Why?
|
| Interferon Type I | 1 | 2013 | 191 | 0.410 |
Why?
|
| Torpedo | 14 | 2009 | 15 | 0.400 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 177 | 0.390 |
Why?
|
| Open Reading Frames | 2 | 2010 | 121 | 0.390 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2016 | 1230 | 0.380 |
Why?
|
| Fluorescent Dyes | 4 | 2017 | 250 | 0.380 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 7 | 2010 | 21 | 0.370 |
Why?
|
| Binding Sites | 11 | 2017 | 1127 | 0.370 |
Why?
|
| Mutation | 7 | 2017 | 4208 | 0.360 |
Why?
|
| Retroviridae | 2 | 2010 | 79 | 0.350 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2010 | 88 | 0.340 |
Why?
|
| Protein Binding | 5 | 2017 | 1508 | 0.320 |
Why?
|
| Protein Folding | 6 | 2005 | 293 | 0.320 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 2 | 2007 | 94 | 0.310 |
Why?
|
| Proteome | 4 | 2021 | 142 | 0.310 |
Why?
|
| Humans | 37 | 2023 | 91261 | 0.310 |
Why?
|
| Leukemia Virus, Murine | 3 | 1998 | 18 | 0.310 |
Why?
|
| Disulfides | 4 | 2013 | 65 | 0.310 |
Why?
|
| Palmitates | 3 | 2009 | 16 | 0.310 |
Why?
|
| Optical Imaging | 3 | 2017 | 50 | 0.310 |
Why?
|
| Ganglionic Stimulants | 1 | 2008 | 7 | 0.300 |
Why?
|
| Synaptic Transmission | 1 | 2009 | 228 | 0.300 |
Why?
|
| Protein Biosynthesis | 3 | 2023 | 390 | 0.290 |
Why?
|
| Cells, Cultured | 10 | 2014 | 2891 | 0.290 |
Why?
|
| Transferases | 2 | 2006 | 23 | 0.290 |
Why?
|
| Mesencephalon | 1 | 2008 | 64 | 0.290 |
Why?
|
| Serotonin 5-HT3 Receptor Antagonists | 1 | 2007 | 18 | 0.280 |
Why?
|
| Polysaccharides | 3 | 2021 | 91 | 0.280 |
Why?
|
| Pyridines | 2 | 2007 | 304 | 0.280 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 2434 | 0.280 |
Why?
|
| Behavior | 1 | 2007 | 84 | 0.280 |
Why?
|
| Quantum Dots | 3 | 2017 | 20 | 0.270 |
Why?
|
| Microscopy, Fluorescence | 4 | 2015 | 439 | 0.270 |
Why?
|
| Green Fluorescent Proteins | 4 | 2017 | 308 | 0.270 |
Why?
|
| Patch-Clamp Techniques | 4 | 2015 | 397 | 0.260 |
Why?
|
| Autoantigens | 2 | 2021 | 132 | 0.260 |
Why?
|
| Glycosylation | 3 | 2021 | 128 | 0.260 |
Why?
|
| Positron-Emission Tomography | 3 | 2023 | 342 | 0.250 |
Why?
|
| Discs Large Homolog 1 Protein | 2 | 2016 | 2 | 0.250 |
Why?
|
| Staining and Labeling | 2 | 2017 | 173 | 0.250 |
Why?
|
| Acetylcholine | 4 | 2010 | 177 | 0.250 |
Why?
|
| Selenoproteins | 1 | 2024 | 21 | 0.230 |
Why?
|
| Behavior, Animal | 1 | 2007 | 383 | 0.230 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2004 | 108 | 0.230 |
Why?
|
| Acetylcysteine | 1 | 2004 | 71 | 0.230 |
Why?
|
| Ubiquitin | 1 | 2004 | 96 | 0.220 |
Why?
|
| Immunoglobulin M | 1 | 2024 | 164 | 0.220 |
Why?
|
| Acylation | 2 | 2017 | 61 | 0.220 |
Why?
|
| Blotting, Western | 3 | 2013 | 795 | 0.210 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 4 | 2007 | 15 | 0.210 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 296 | 0.210 |
Why?
|
| Models, Biological | 3 | 2020 | 1772 | 0.200 |
Why?
|
| Radioligand Assay | 4 | 2005 | 32 | 0.200 |
Why?
|
| Carrier Proteins | 4 | 2007 | 679 | 0.200 |
Why?
|
| Peptide Fragments | 4 | 2009 | 465 | 0.190 |
Why?
|
| Cell Membrane | 8 | 2014 | 682 | 0.190 |
Why?
|
| Acyltransferases | 4 | 2011 | 51 | 0.190 |
Why?
|
| Retinal Detachment | 1 | 2002 | 69 | 0.190 |
Why?
|
| Lymphocyte Activation | 1 | 2024 | 759 | 0.190 |
Why?
|
| Ventral Tegmental Area | 2 | 2013 | 44 | 0.180 |
Why?
|
| Mass Spectrometry | 2 | 2013 | 196 | 0.180 |
Why?
|
| Chickens | 3 | 2010 | 212 | 0.180 |
Why?
|
| Mitochondrial Myopathies | 1 | 2000 | 2 | 0.180 |
Why?
|
| Leigh Disease | 1 | 2000 | 3 | 0.180 |
Why?
|
| Secretory Pathway | 1 | 2020 | 22 | 0.180 |
Why?
|
| Neuromuscular Junction | 3 | 2010 | 81 | 0.170 |
Why?
|
| Alkylation | 4 | 2006 | 32 | 0.170 |
Why?
|
| Eye Diseases | 1 | 2000 | 60 | 0.170 |
Why?
|
| Batrachotoxins | 3 | 1991 | 3 | 0.170 |
Why?
|
| Nucleus Accumbens | 3 | 2013 | 113 | 0.170 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2000 | 20 | 0.160 |
Why?
|
| Point Mutation | 1 | 2000 | 246 | 0.160 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 743 | 0.160 |
Why?
|
| Protein Disulfide-Isomerases | 2 | 2010 | 18 | 0.160 |
Why?
|
| Sodium | 3 | 1995 | 334 | 0.160 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2020 | 452 | 0.150 |
Why?
|
| Gene Products, gag | 1 | 1998 | 12 | 0.150 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1567 | 0.150 |
Why?
|
| CD40 Antigens | 1 | 1998 | 43 | 0.150 |
Why?
|
| Long-Term Potentiation | 2 | 2015 | 48 | 0.140 |
Why?
|
| Antigens, Viral | 1 | 1998 | 146 | 0.140 |
Why?
|
| Tetrodotoxin | 3 | 1991 | 50 | 0.140 |
Why?
|
| Saxitoxin | 2 | 1987 | 8 | 0.140 |
Why?
|
| Cerebral Cortex | 3 | 2012 | 592 | 0.140 |
Why?
|
| Protein Stability | 1 | 2017 | 101 | 0.130 |
Why?
|
| Oxidation-Reduction | 2 | 2013 | 395 | 0.130 |
Why?
|
| Cysteine | 3 | 2013 | 144 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2024 | 2058 | 0.130 |
Why?
|
| Cyclic AMP | 3 | 1994 | 279 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 499 | 0.130 |
Why?
|
| Protein Domains | 1 | 2016 | 140 | 0.130 |
Why?
|
| Colforsin | 4 | 1994 | 74 | 0.130 |
Why?
|
| Amino Acid Sequence | 6 | 2009 | 2077 | 0.130 |
Why?
|
| Proteomics | 2 | 2008 | 242 | 0.130 |
Why?
|
| Cholinergic Agents | 2 | 2010 | 17 | 0.120 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2015 | 11 | 0.120 |
Why?
|
| Brain Chemistry | 3 | 2007 | 121 | 0.120 |
Why?
|
| Kidney | 3 | 2007 | 1154 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1695 | 0.120 |
Why?
|
| Time Factors | 5 | 2017 | 5394 | 0.120 |
Why?
|
| Tissue Distribution | 2 | 2017 | 293 | 0.120 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2015 | 55 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2023 | 1995 | 0.120 |
Why?
|
| Single-Domain Antibodies | 1 | 2014 | 5 | 0.120 |
Why?
|
| Mutagenesis | 1 | 2015 | 202 | 0.120 |
Why?
|
| Biotinylation | 2 | 2005 | 43 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 2620 | 0.120 |
Why?
|
| DNA, Complementary | 1 | 2015 | 391 | 0.120 |
Why?
|
| Membrane Potentials | 4 | 2010 | 436 | 0.110 |
Why?
|
| DNA Primers | 1 | 2015 | 546 | 0.110 |
Why?
|
| Cloning, Molecular | 1 | 2015 | 646 | 0.110 |
Why?
|
| Epitopes | 2 | 2007 | 255 | 0.110 |
Why?
|
| Electrophoresis | 1 | 2013 | 54 | 0.110 |
Why?
|
| Iodine Radioisotopes | 2 | 2007 | 135 | 0.110 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 303 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2015 | 898 | 0.100 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2013 | 97 | 0.100 |
Why?
|
| Dopaminergic Neurons | 1 | 2013 | 26 | 0.100 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 144 | 0.100 |
Why?
|
| Male | 7 | 2022 | 43367 | 0.100 |
Why?
|
| Kinetics | 6 | 2023 | 1549 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1881 | 0.100 |
Why?
|
| Ethylmaleimide | 2 | 2004 | 11 | 0.100 |
Why?
|
| Lipid Bilayers | 3 | 1987 | 137 | 0.100 |
Why?
|
| Species Specificity | 1 | 2013 | 690 | 0.100 |
Why?
|
| Dopamine | 2 | 2013 | 273 | 0.100 |
Why?
|
| Pigment Epithelium of Eye | 2 | 2002 | 13 | 0.090 |
Why?
|
| Locomotion | 1 | 2013 | 140 | 0.090 |
Why?
|
| Huntington Disease | 1 | 2011 | 39 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 1591 | 0.090 |
Why?
|
| Structure-Activity Relationship | 4 | 2017 | 429 | 0.090 |
Why?
|
| Theophylline | 1 | 1991 | 34 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2009 | 565 | 0.090 |
Why?
|
| Frameshifting, Ribosomal | 1 | 2010 | 5 | 0.090 |
Why?
|
| Codon, Initiator | 1 | 2010 | 22 | 0.090 |
Why?
|
| Thionucleotides | 1 | 1991 | 55 | 0.090 |
Why?
|
| Frameshift Mutation | 1 | 2010 | 51 | 0.090 |
Why?
|
| Synaptosomes | 2 | 1987 | 10 | 0.090 |
Why?
|
| Macromolecular Substances | 4 | 1998 | 177 | 0.090 |
Why?
|
| Iodine Isotopes | 1 | 2010 | 18 | 0.090 |
Why?
|
| Reaction Time | 1 | 2012 | 312 | 0.090 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 32 | 0.090 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2008 | 96 | 0.090 |
Why?
|
| Cell Compartmentation | 2 | 2009 | 70 | 0.090 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2010 | 217 | 0.090 |
Why?
|
| Electric Organ | 1 | 2009 | 5 | 0.080 |
Why?
|
| Bodily Secretions | 1 | 2009 | 3 | 0.080 |
Why?
|
| Sodium Channels | 2 | 1991 | 130 | 0.080 |
Why?
|
| Antigen Presentation | 1 | 2010 | 215 | 0.080 |
Why?
|
| Biological Assay | 1 | 2009 | 81 | 0.080 |
Why?
|
| Presynaptic Terminals | 1 | 2009 | 41 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2009 | 3031 | 0.080 |
Why?
|
| PC12 Cells | 2 | 2000 | 115 | 0.080 |
Why?
|
| Precipitin Tests | 2 | 2007 | 111 | 0.080 |
Why?
|
| Receptors, Serotonin | 2 | 1999 | 34 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2009 | 143 | 0.080 |
Why?
|
| Membrane Microdomains | 1 | 2008 | 54 | 0.080 |
Why?
|
| Glutamic Acid | 1 | 2009 | 154 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2010 | 695 | 0.080 |
Why?
|
| Gene Expression | 3 | 2017 | 1313 | 0.080 |
Why?
|
| Female | 5 | 2022 | 47287 | 0.070 |
Why?
|
| Organogenesis | 1 | 2008 | 50 | 0.070 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2007 | 4 | 0.070 |
Why?
|
| Mecamylamine | 1 | 2007 | 4 | 0.070 |
Why?
|
| Nicotinic Antagonists | 1 | 2007 | 3 | 0.070 |
Why?
|
| Cell Fractionation | 1 | 2007 | 71 | 0.070 |
Why?
|
| Subcellular Fractions | 1 | 2007 | 94 | 0.070 |
Why?
|
| Solubility | 1 | 2007 | 184 | 0.070 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2008 | 145 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 183 | 0.070 |
Why?
|
| Action Potentials | 2 | 2009 | 605 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 3 | 2009 | 742 | 0.070 |
Why?
|
| Acetyltransferases | 1 | 2006 | 36 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2009 | 3448 | 0.060 |
Why?
|
| Asparagine | 1 | 2005 | 30 | 0.060 |
Why?
|
| Chaperonins | 2 | 2003 | 10 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2004 | 53 | 0.060 |
Why?
|
| Proteasome Inhibitors | 1 | 2004 | 52 | 0.060 |
Why?
|
| Models, Neurological | 2 | 2008 | 417 | 0.060 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2004 | 51 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 3313 | 0.060 |
Why?
|
| Tritium | 1 | 2004 | 133 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2009 | 281 | 0.060 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2004 | 14 | 0.060 |
Why?
|
| Plasma Cells | 1 | 2024 | 85 | 0.050 |
Why?
|
| Biological Transport | 2 | 2009 | 403 | 0.050 |
Why?
|
| Internal Ribosome Entry Sites | 1 | 2023 | 16 | 0.050 |
Why?
|
| Genetic Vectors | 2 | 2004 | 448 | 0.050 |
Why?
|
| Temperature | 3 | 2001 | 404 | 0.050 |
Why?
|
| Fibroblasts | 5 | 2001 | 767 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 294 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2001 | 1404 | 0.050 |
Why?
|
| Glucose | 1 | 2005 | 631 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 731 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 244 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2002 | 345 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2001 | 130 | 0.050 |
Why?
|
| Optic Atrophy | 1 | 2000 | 4 | 0.040 |
Why?
|
| Ciliary Body | 1 | 2000 | 7 | 0.040 |
Why?
|
| Tetrahymena | 1 | 2020 | 37 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 284 | 0.040 |
Why?
|
| Thymidine | 1 | 2000 | 59 | 0.040 |
Why?
|
| Optic Disk | 1 | 2000 | 14 | 0.040 |
Why?
|
| Endothelium, Corneal | 1 | 2000 | 19 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2000 | 48 | 0.040 |
Why?
|
| Retinal Hemorrhage | 1 | 2000 | 8 | 0.040 |
Why?
|
| Isomerism | 1 | 2000 | 29 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1997 | 112 | 0.040 |
Why?
|
| Optic Nerve | 1 | 2000 | 36 | 0.040 |
Why?
|
| Glycosaminoglycans | 1 | 2000 | 47 | 0.040 |
Why?
|
| Edema | 1 | 2000 | 71 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 1 | 2000 | 72 | 0.040 |
Why?
|
| Nerve Degeneration | 1 | 2000 | 83 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2000 | 299 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2000 | 189 | 0.040 |
Why?
|
| Chimera | 1 | 1999 | 56 | 0.040 |
Why?
|
| Peptides | 2 | 2006 | 660 | 0.040 |
Why?
|
| Guanine | 1 | 2000 | 207 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2000 | 74 | 0.040 |
Why?
|
| Atrophy | 1 | 2000 | 125 | 0.040 |
Why?
|
| Epithelium | 1 | 2000 | 323 | 0.040 |
Why?
|
| Retinal Diseases | 1 | 2000 | 91 | 0.040 |
Why?
|
| Permeability | 2 | 1991 | 139 | 0.040 |
Why?
|
| Electrophysiology | 2 | 2008 | 402 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2000 | 532 | 0.040 |
Why?
|
| Splenomegaly | 1 | 1998 | 28 | 0.040 |
Why?
|
| Defective Viruses | 1 | 1998 | 12 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 1998 | 16 | 0.040 |
Why?
|
| Aconitine | 1 | 1997 | 4 | 0.040 |
Why?
|
| Succinimides | 1 | 1997 | 12 | 0.040 |
Why?
|
| CD40 Ligand | 1 | 1998 | 71 | 0.040 |
Why?
|
| COS Cells | 2 | 2009 | 167 | 0.040 |
Why?
|
| Dithiothreitol | 1 | 1997 | 25 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 475 | 0.040 |
Why?
|
| Cystine | 1 | 1997 | 15 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 1998 | 1016 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2023 | 2034 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 1997 | 89 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 77 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1998 | 93 | 0.040 |
Why?
|
| Methionine | 1 | 1997 | 67 | 0.040 |
Why?
|
| Electric Conductivity | 2 | 1987 | 144 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2017 | 88 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 304 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 223 | 0.030 |
Why?
|
| Macrophages | 1 | 2000 | 591 | 0.030 |
Why?
|
| Dogs | 2 | 1987 | 704 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 1049 | 0.030 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2008 | 66 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 616 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 1998 | 476 | 0.030 |
Why?
|
| Endopeptidases | 2 | 2008 | 118 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 1102 | 0.030 |
Why?
|
| Single-Chain Antibodies | 1 | 2014 | 18 | 0.030 |
Why?
|
| Molecular Probes | 1 | 2014 | 35 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 1995 | 107 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 136 | 0.030 |
Why?
|
| Muscles | 3 | 2008 | 192 | 0.030 |
Why?
|
| Ion Channel Gating | 2 | 2000 | 330 | 0.030 |
Why?
|
| Microtubules | 1 | 2014 | 129 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 1997 | 538 | 0.030 |
Why?
|
| Potassium | 1 | 1995 | 259 | 0.030 |
Why?
|
| Base Sequence | 1 | 1998 | 2329 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1994 | 108 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1936 | 0.030 |
Why?
|
| Infant | 1 | 2000 | 3207 | 0.030 |
Why?
|
| Disease Progression | 1 | 1998 | 1497 | 0.030 |
Why?
|
| Central Nervous System Sensitization | 1 | 2013 | 10 | 0.030 |
Why?
|
| GABAergic Neurons | 1 | 2013 | 18 | 0.030 |
Why?
|
| Phosphorylation | 2 | 1994 | 1132 | 0.030 |
Why?
|
| Phospholipids | 2 | 2009 | 112 | 0.030 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2011 | 6 | 0.020 |
Why?
|
| Enkephalins | 1 | 2011 | 16 | 0.020 |
Why?
|
| Risk Factors | 1 | 2002 | 5619 | 0.020 |
Why?
|
| Electrolytes | 1 | 1991 | 53 | 0.020 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2011 | 48 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 1991 | 21 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1991 | 56 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 97 | 0.020 |
Why?
|
| Photobleaching | 1 | 2010 | 8 | 0.020 |
Why?
|
| Algorithms | 2 | 2014 | 1936 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 2011 | 88 | 0.020 |
Why?
|
| DNA | 2 | 2000 | 1313 | 0.020 |
Why?
|
| Surface Properties | 1 | 1991 | 130 | 0.020 |
Why?
|
| Calcium | 1 | 1995 | 1182 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 258 | 0.020 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 1990 | 139 | 0.020 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2009 | 10 | 0.020 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2008 | 12 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2008 | 39 | 0.020 |
Why?
|
| Apolipoprotein A-I | 1 | 2009 | 70 | 0.020 |
Why?
|
| Motor Activity | 1 | 2011 | 326 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2008 | 41 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2008 | 100 | 0.020 |
Why?
|
| Acetylcholinesterase | 1 | 2008 | 48 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 279 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2008 | 129 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 231 | 0.020 |
Why?
|
| Cadherins | 1 | 2008 | 165 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2008 | 132 | 0.020 |
Why?
|
| Cholesterol | 1 | 2009 | 362 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2008 | 215 | 0.020 |
Why?
|
| Mathematics | 1 | 1987 | 191 | 0.020 |
Why?
|
| Genes | 1 | 1987 | 306 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2008 | 159 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2008 | 471 | 0.020 |
Why?
|
| Zinc | 1 | 1987 | 97 | 0.020 |
Why?
|
| Motor Neurons | 1 | 2008 | 178 | 0.020 |
Why?
|
| Huntingtin Protein | 1 | 2006 | 13 | 0.020 |
Why?
|
| Inclusion Bodies | 1 | 2006 | 34 | 0.020 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2006 | 24 | 0.020 |
Why?
|
| Amphibian Proteins | 1 | 1986 | 4 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 888 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 984 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2009 | 1327 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 523 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 521 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 520 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1806 | 0.010 |
Why?
|
| Presenilin-2 | 1 | 2002 | 25 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 2002 | 100 | 0.010 |
Why?
|
| Aged | 1 | 2000 | 19618 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2002 | 214 | 0.010 |
Why?
|
| Immunoblotting | 2 | 1991 | 272 | 0.010 |
Why?
|
| Carcinoma, Brown-Pearce | 1 | 1979 | 1 | 0.010 |
Why?
|
| Eye Neoplasms | 1 | 1979 | 26 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1980 | 313 | 0.010 |
Why?
|
| Methotrexate | 1 | 1979 | 244 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1991 | 324 | 0.010 |
Why?
|
| Phosphoserine | 1 | 1994 | 9 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1994 | 26 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1994 | 97 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1994 | 275 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1991 | 39 | 0.010 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1991 | 7 | 0.010 |
Why?
|
| Acetylglucosaminidase | 1 | 1991 | 5 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 1991 | 38 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1991 | 332 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 270 | 0.010 |
Why?
|
| Photomicrography | 1 | 1990 | 7 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1980 | 15 | 0.000 |
Why?
|
| Immune Sera | 1 | 1980 | 52 | 0.000 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1980 | 22 | 0.000 |
Why?
|
| Virus Diseases | 1 | 1980 | 103 | 0.000 |
Why?
|
| Anterior Chamber | 1 | 1979 | 10 | 0.000 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1979 | 34 | 0.000 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 1979 | 18 | 0.000 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1979 | 25 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1979 | 511 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1979 | 397 | 0.000 |
Why?
|
| Rabbits | 1 | 1979 | 642 | 0.000 |
Why?
|
| Neoplasms, Experimental | 1 | 1979 | 270 | 0.000 |
Why?
|